US Cardiology Review (Feb 2023)

Clozapine-induced Cardiomyopathy: A Case Report

  • Essa Hariri,
  • Anna Scandinaro,
  • Mazen M Al Hammoud,
  • Ashley Kasper,
  • Craig Parris,
  • Beka Bakhtadzi,
  • Andrew Higgins

DOI
https://doi.org/10.15420/usc.2022.22
Journal volume & issue
Vol. 17

Abstract

Read online

The diagnosis and treatment of new-onset systolic dysfunction can be challenging, particularly in patients presenting with cardiogenic shock. We present a case of a young African-American male who was admitted for cardiogenic shock following an admission a month earlier for treatmentresistant psychosis. He was diagnosed with medication-induced cardiomyopathy, which resolved with a remarkable recovery of his systolic function after discontinuation of the culprit medication, clozapine.